Hoobler Rachel, Herrera Manuela, Woodruff Kary, Sanchez Alejandro, Coletta Adriana M, Chaix Amandine, Elizondo Joan, Playdon Mary C
Department of Nutrition & Integrative Physiology, University of Utah, Salt Lake City, Utah; Cancer Control and Population Sciences, Huntsman Cancer Institute, Salt Lake City, Utah.
Department of Nutrition & Integrative Physiology, University of Utah, Salt Lake City, Utah.
J Acad Nutr Diet. 2025 Sep;125(9):1242-1255.e10. doi: 10.1016/j.jand.2025.04.014. Epub 2025 May 5.
Studies investigating the association of malnutrition with mortality and complications of cancer treatment in oncology patients are primarily restricted to head and neck and gastrointestinal cancers. Yet, malnutrition risk factors are experienced across cancer types.
To evaluate the association of malnutrition risk, assessed by the Malnutrition Screening Tool, with all-cause mortality and complications of chemotherapy and radiation among oncology patients.
A retrospective cohort study using electronic medical record data from January 2021 to April 2024.
PARTICIPANTS/SETTING: Two thousand eight hundred fifty-nine adult cancer patients with a Malnutrition Screening Tool score within 1 year of a cancer diagnosis were included. Patients were treated at 9 outpatient clinics in the western United States.
The primary outcome was all-cause mortality. Secondary outcomes were complications of chemotherapy and radiation.
Cox proportional hazards regression, adjusted for key confounders, was used to evaluate the association of malnutrition risk with time to death from any cause. A secondary analysis stratified by cancer type was conducted when sample size permitted. Multivariable logistic regression was used to assess the association of malnutrition risk with the first treatment-related complication.
Malnutrition risk, compared with no risk, was significantly associated with increased risk for all-cause mortality for all cancer patients combined (hazard ratio 1.70; 95% CI, 1.39-2.07; P < .001) and some specific cancer types, such as lung cancer (hazard ratio 1.58; 95% CI, 1.05 to 2.37; P = .03). Malnutrition risk was also associated with increased likelihood of complications of chemotherapy in all cancers combined (odds ratio 1.49; 95% CI, 1.11-2.00; P < .01).
Malnutrition risk was associated with elevated risk of mortality and chemotherapy complications for all cancers combined. These results highlight the importance of malnutrition risk in cancer prognosis.
关于营养不良与肿瘤患者癌症治疗的死亡率和并发症之间关联的研究主要局限于头颈癌和胃肠道癌。然而,不同类型癌症患者都存在营养不良风险因素。
通过营养不良筛查工具评估营养不良风险与肿瘤患者全因死亡率以及化疗和放疗并发症之间的关联。
一项回顾性队列研究,使用2021年1月至2024年4月的电子病历数据。
参与者/研究地点:纳入2859例成年癌症患者,这些患者在癌症诊断后1年内有营养不良筛查工具评分。患者在美国西部的9家门诊接受治疗。
主要结局是全因死亡率。次要结局是化疗和放疗的并发症。
采用Cox比例风险回归,并对关键混杂因素进行调整,以评估营养不良风险与任何原因导致的死亡时间之间的关联。当样本量允许时,按癌症类型进行了分层的二次分析。多变量逻辑回归用于评估营养不良风险与首次治疗相关并发症之间的关联。
与无风险相比,营养不良风险与所有癌症患者综合全因死亡率风险增加显著相关(风险比1.70;95%置信区间,1.39 - 2.07;P < .001)以及某些特定癌症类型,如肺癌(风险比1.58;95%置信区间,1.05至2.37;P = .03)。营养不良风险还与所有癌症综合化疗并发症发生可能性增加相关(优势比1.49;95%置信区间,1.11 - 2.00;P < .01)。
营养不良风险与所有癌症综合的死亡率和化疗并发症风险升高相关。这些结果凸显了营养不良风险在癌症预后中的重要性。